iCAD announced a strategic partnership with Densitas…The partnership enables breast imaging centers and radiologists to provide end-to-end breast health care that ensures every aspect of a woman’s breast health journey is addressed, starting from the first step of quality screening mammograms and extending through breast cancer detection, breast density assessment, and a comprehensive evaluation of breast cancer risk. “We are thrilled to announce this strategic collaboration with Densitas to offer physicians and patients a more comprehensive, holistic approach to precision breast health care,” said Dana Brown, President and CEO of iCAD. “By combining Densitas’ AI-powered intelliMammo platform with iCAD’s AI-powered ProFound Breast Health Suite, we are transforming early breast cancer detection and intervention.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICAD:
- iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation
- iCAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting
- iCAD partners with RAD-AID to advance breast cancer detection
- iCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale
- iCAD announces commercial availability of ProFound Cloud
